Story Stocks^®

UiPath (PATH) is diving lower after reporting its Q4 results, despite the company's beat-and-raise performance. Management highlighted strong execution, AI momentum, enterprise expansion, and a new $500 mln stock repurchase program. The selloff appears driven by concerns over decelerating growth, with the midpoint of FY27 revenue guidance implying 9% yr/yr growth compared to 13% in FY26.

• ARR grew 11% yr/yr to $1.853 bln with $70 mln net new ARR (including $14 mln FX tailwind), reflecting stabilization and AI-driven expansion. Dollar-based net retention held steady at 107% (106% FX-neutral).
• Cloud ARR exceeded $1.2 bln (up over 20% yr/yr), with AI product ARR nearing $200 mln and strong attachment rates (90% of greater than $1 mln ARR customers, 60% of over $100K ARR customers using AI products).
• Q4 non-GAAP operating income hit $150 mln (31% margin), with full-year GAAP profitability achieved for the first time. RPO rose 19% to $1.475 bln.
• Customer metrics improved, with over 50% y/y growth in $1 mln+ ARR deals, 357 such customers, and net additions of large customers at a 2-year high.
• Guidance implies first-half FY27 net new ARR of $73 mln, with revenue seasonality similar to FY26 (30% in Q4). SaaS growth adds a 1% revenue headwind but supports cloud shift.
• Despite the beat-and-raise, the market fixated on FY27 revenue growth slowing to 9% midpoint from 13% in FY26, overlooking AI flywheel strength (e.g., agentic + IDP adoption layering on core unattended automation) and operating leverage (updated 30% long-term non-GAAP op margin).
• PATH emphasized its unified platform advantages in an "agentic era" - combining deterministic/agentic automation with governance - positioning it for AI expansion rather than displacement, as seen in partnerships (Deloitte Agentic ERP, Accenture) and verticals like healthcare/financial services.
• The $500 mln repurchase signals board confidence in cash flows ($1.7 bln cash, no debt, FY27 FCF $425 mln guided), potentially supporting valuation amid growth worries.

Briefing.com Analyst Insight

While PATH's Q4 beat and FY27 raise delivered on execution, capping a year of GAAP profitability, ARR stabilization at $1.853 bln, and AI ARR momentum nearing $200 mln, this was overshadowed by revenue growth deceleration to 9% implied for FY27 vs. 13% prior, fueling the sharp selloff. Net new ARR of $70 mln and 107% NRR reflect a stabilizing base with AI expansion, but macro variability and SaaS transition headwinds tempered optimism. Positives include cloud ARR 20%+ growth to $1.2 bln, record large-deal wins, and structural tailwinds from agentic automation in regulated verticals. The new $500 mln buyback underscores capital return discipline amid $1.7 bln cash. Focus ahead will be on AI product scaling, net new ARR acceleration, cloud migration progress, and navigating federal/macro dynamics, though today's reaction seems overdone given profitability ramp and platform differentiation.